Media Center

EGA and EBG welcome a new milestone in the EU Biosimilars medicines regulatory framework

Brussels, October 30, 2014 - The EGA and the European Biosimilars Group (EBG), a sector group of the EGA, congratulate the EMA and its Committee for Medicinal Products for Human Use (CHMP) and Biosimilar Medicines Working Party (BMWP) for adopting its revised overarching guideline on biosimilar medicines.

Click here to read the full EGA press release.